Point72 »

Celldex Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-03-31 $471k 11k 41.97

More positions owned by Point72

Target Corporation Call Option (TGT)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Oracle Corporation (ORCL)
Wal-Mart Stores (WMT)
Raytheon Technologies Corp Call Option (RTX)
Lockheed Martin Corporation Call Option (LMT)
Adobe Systems Incorporated (ADBE)
General Motors Company (GM)
Eli Lilly & Co. Call Option (LLY)
Netflix Call Option (NFLX)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
UnitedHealth (UNH)
At&t Call Option (T)
Nextera Energy Call Option (NEE)

View all positions for Point72

Top funds holding Celldex Therapeutics

FMR
Wellington Management Company
BlackRock
Vanguard Group
Eventide Asset Management
T. Rowe Price Associates
Kynam Capital Management
Bellevue Group
Pictet Asset Management Holding SA
Geode Capital Management
Rock Springs Capital Management
Point72 Asset Management
Marshall Wace
Redmile Group
Commodore Capital

View all funds holding Celldex Therapeutics